Cell responses to oxidative stressors

Current Pharmaceutical Design

Volumn 16, Issue 12, 2010, Pages 1387-1395

  Cataldi, Amelia ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Eukaryotic cells; Mitochondria; Oxidative stressors; ROS; Signalling pathways

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ESTRADIOL BENZOATE PLUS PROGESTERONE; ETOPOSIDE; FLUOROURACIL; HYPOXIA INDUCIBLE FACTOR 1; MITOMYCIN; NITRIC OXIDE; PROTEIN KINASE C; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RESVERATROL; TELOMERASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

CELL AGING; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; DNA DAMAGE; EUKARYOTIC CELL; HOMEOSTASIS; HUMAN; HYPEROXIA; HYPOXIA; IONIZING RADIATION; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; OXYGEN SENSING; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TELOMERE;

EID: 77950868170     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210791033969     Document Type: Review

References (134)

1. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 2000; 408: 239-247.
2. Gutzeit HO. Interaction of stressors and the limits of cellular homeostasis. Biochem Biophys Res Commun 2001; 283: 721-725.
3. Kultz D. Molecular and evolutionary basis of the cellular stress response. Annu Rev Physiol 2005; 67: 225-257. (Pubitemid 40404492)
4. Alridge DR, Ratford IR. Explaining differences in sensitivity to killing by ionizing radiation between human lymphoid cell lines. Cancer Res 1998; 58: 2817-2824.
5. Watters D. Molecular mechanisms of ionizing radiation induced apoptosis. Immunol Cell Biol 1999; 77: 263-268. (Pubitemid 29251580)
6. Sabatini N, di Giacomo V, Rapino M, Rana RA, Garaci FG, Cataldi A. JNK/p53 mediated cell death response in K562 exposed to etoposide-ionizing radiation combined treatment. J Cell Biochem 2005; 95: 611-619. (Pubitemid 41420189)
7. Cataldi A, di Giacomo V, Rapino M, Genovesi D, Rana RA. CREB activation promotes survival signal in human K562 erythroleukemia cells exposed to ionizing radiation/etoposide combined treatment. J Rad Res 2006; 47: 113-120.
8. Lindsay KJ, Coates PJ, Lorimore SA, Wright EG. The genetic basis of tissue responses to ionizing radiation. Br J Radiol 2007; 80: 52-56.
9. Cohen-Jonathan E, Bernhard EJ, McKenna WG. How does radiation kill cells? Curr Opin Chem Biol 1999; 3: 77-83.
10. Valerie K, Yacoub A, Hagan MP, Curiel DT, Fisher PB, Grant S, et al. Radiation-induced cell signalling: inside-out and outside-in. Mol Cancer Ther 2007; 6: 789-801. (Pubitemid 46554549)
11. Vogelstein B, Lane D, Levriere AJ. Surfing the p53 network. Nature 2000; 408: 307-310.
12. Shimokawa N, Qiu CH, Seki T, Dikic I, Koibuchi N. Phosphorylation of JNK is involved in regulation of H+ induced c-Jun expression. Cell Signal 2004; 16: 723-729. (Pubitemid 38490554)
13. Di Pietro R, Centurione L, Sabatini N, Bosco D, Sancilio S, Garaci F, et al. Caspase-3 is dually regulated by apoptogenic factors mitochondrial release and by SAPK/JNK metabolic pathway in leukemic cells exposed to etoposide/ionizing radiation combined treatment. Int J Immunopathol Pharmacol 2004; 17: 181-190.
14. Cataldi A, Rapino M, Centurione L, Sabatini N, Grifone G, Garaci F, et al. NF-κB plays an antiapoptotic role in human leukemic K562 cells exposed to ionizing radiation. J Cell Biochem 2003; 89: 956-963.
15. Hagan M, Yacoub A, Dent P. Ionizing radiation causes a dose-dependent release of transforming growth factor α in vitro from irradiated xenografts and during palliative treatment of hormone-refractory prostate carcinoma. Clin Cancer Res 2004; 2: 5724-5731.
16. Grant S, Fisher PB, Dent P. The role of signal transduction pathways in the control of cell growth and survival. Cancer Treatm Res 2002; 112: 89-108.
17. Yacoub A, Miller A, Caron RW, Qiao L, Curiel DA, Fisher PB, et al. Radiotherapy-induced signal transduction. Endocr Relat Cancer 2006; 13: S99-114.
18. Guillemin K, Krasnow MA. The hypoxic response: huffing and HIFing. Cell 1997; 89: 9-12.
19. Kumar GK, Prabhakar NR. Post-translational modification of proteins during intermittent hypoxia. Respir Physiol Neurobiol 2008; 164: 272-276.
20. Bunn HF, Poyton RO. Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 1996; 839-885.
21. Poyton RO. Models for oxygen sensing in yeast: implications for oxygen regulated gene expression in higher eukaryotes. Respir Physiol 1999; 115: 119-133.
22. Wenger RH. Mammalian oxygen sensing, signalling and gene regulation. Exp Biol 2000; 203: 1253-1263.
23. Freeman BA, Crapo JD. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J Biol Chem 1981; 256: 10986-10992.
24. Cataldi A, Grilli A, Antonucci A, Bosco D, Di Giulio C, Castorina S, et al. Ultrastructural modifications and PI-3-kinase expression and activity in myocardial tissue deriving from rats in different experimental conditions. Cell Struct Funct 2001; 26: 87-93.
25. Stuhr LE, Raa A, Oyan AM, Kalland KH, Sakariassen PO, Petersen K, et al. Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats. J Neurooncol 2007; 85: 191-202. (Pubitemid 47629400)
26. Chandel NS, Budinger GR. The cellular basis for diverse response to oxygen. Free Rad Biol Med 2007; 42: 165-174.
27. Kulkarni AC, Kuppusamy P, Parinandi N. Oxygen, the lead actor in the pathophysiologic drama: enactment of the trinità of normoxia, hypoxia and hyperoxia in diseases and therapy. Antioxid Redox Signal 2007; 9: 1717-1730.
28. Bitterman H, Reissman P, Bitterman N, Melamed Y, Cohen L. Oxygen therapy in hemorrhagic shock. Circ Shock 1991; 33: 183-191.
29. Aydin A, Ozden BC, Karamursel S, Solakoglu S, Aktas S, Erer M. Effect of hyperbaric oxygen therapy on nerve regeneration in early diabetes. Microsurgery 2004; 24: 255-261. (Pubitemid 38720809)
30. Yogaratnam JZ, Laden G, Guvendik L, Cowen M, Cale A, Griffin S. Hyperbaric oxygen: a novel technology for modulating myocardial ischemia-reperfusion via a single drug. Adv Ther 2006; 23: 528-533. (Pubitemid 44747433)
31. Quintero P, Milagro FI, Campion J, Martinez JA. Impact of oxygen availability on body weight management. Med Hypotheses 2009; [Epub ahead of print].
32. Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 2005; 37: 961-976. (Pubitemid 40311739)
33. Ben-Porath I, Weinberg RA. When cells get stressed: an integrative view of cellular senescence. J Clin Invest 2004; 113: 8-13. (Pubitemid 38541623)
34. von Figura G, Rudolph KL. Cancer and aging-biological mechanisms Onkologie 2009; 32: 34-38.
35. Finkel T. Oxidant signals and oxidative stress. Curr Opin Cell Biol 2003; 15: 247-254.
36. Wickens AP. Ageing and the free radical theory. Respir Physiol 2001; 128: 379-391.
37. Markesbery WR, Carney JM. Oxidative alterations in Alzheimer's disease. Brain Pathol 1999; 9: 133-146.
38. Tiligada E. Chemotherapy: induction of stress responses. Endocr Relat Cancer 2006; 13: S115-24.
39. Sabatini N, Di Pietro R, Rapino M, Sancilio S, Comani S, Cataldi A. PI-3-kinase /Nf-kB mediated response of Jurkat T leukemic cells to two different chemoterapeutic drugs etoposide and TRAIL. J Cell Biochem 2004; 93: 301-311. (Pubitemid 44264207)
40. Sordet O, Goldman A, Redon C, Solier S, Rao VA, Pommier Y. Topoisomerase I requirement for death receptor-induced apèoptotic nuclear fission. J Biol Chem 2008; 283: 23200-23208.
41. Ungvari Z, Labinskyy N, Mukhopadhyay P, Pinto JT, Bagi Z, Ballabh P, et al. Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol 2009; 297: H1876-81.
42. Matsunaga T, Tsuji Y, Kohno S, Hirayama R, Alpers DH, Komoda T, et al. Toxicity against gastric cancer cells by combined treatment with 5-fluorouracil and mitomycin c: implication in oxidative stress. Cancer Chemother Pharmacol 2009; [Epub ahead of print].
43. Pantos C, Malliopoulou V, Varonos DD, Cokkinos DV. Thyroid hormone and phenotypes of cardioprotection. Basic Resin Cardiol 2004; 99: 101-120.
44. Tomida A, Tsuruo T. Drug resistance mediated by cellular stress response to microenvironment of solid tumours. Anti-cancer Drug Design 1999; 14: 169-177. (Pubitemid 29292313)
45. Landriscina M, Maddalena F, Laudiero G, Esposito F. Adaptation to oxidative stress, chemoresistance and cell survival. Antioxid Redox Signal 2009; 11: 2701-2716.
46. Korkaya H, Wicha MS. Selective targeting of cancer stem cells: a new concept in cancer therapeutics. BioDrugs 2007; 21: 299-310. (Pubitemid 47529469)
47. Scheffher IE. Mitochondria. New York: Wiley-Liss Ed. 1999.
48. Jezek P, Hlavata L. Mitochondria in homeostasis of reactive oxygen species in cell, tissues and organism. Int J Biochem Cell Biol 2005; 37: 2478-2503. (Pubitemid 41400319)
49. Manoli I, Alesci S, Blackman MR, Su YA, Rennert O, Chrousos GP. Mitochondria as key components of the stress response. Trends Endocrinol Metab 2007; 18: 190-198. (Pubitemid 46970733)
50. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44-84. (Pubitemid 44566469)
51. Rhee SG, Bae YS, Lee SR, Kwon J. Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE 2000; 53: PE1.
52. Brookes PS. Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release. J Biol Chem 2000; 275: 20474-20479. (Pubitemid 30457626)
53. McCann SM. The nitric oxide hypothesis of brain aging. Exp Gerontol 1997; 32: 431-440. (Pubitemid 27366481)
54. Ergenekon E, Gucuyener K. Nitric oxide in developing brain. Eur J Paediatr 1998; 2: 297-301.
55. Michurina T, Krasnov P, Balazas A, Nakaya N, Vasilieva T, Kuzin B, et al. Nitric oxide is a regulator of hematopoietic stem cell activity. Mol Ther 2004; 10: 241-248. (Pubitemid 39117870)
56. Chung HT, Pae HO, Choi BM, Billiar TR, Kim YI. Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun 2001; 282: 1075-1079.
57. Brune B, Lapetina G. Protein thiol modification of glyceraldehydes-3- phosphate dehydrogenase as a target for nitric oxide signalling. Gen Eng 1995; 17: 149-164.
58. Gow AJ, Buerk DG, Ischiropoulos H. A novel reaction mechanism for the formation of S-nitrosothiol in vivo. J Biol Chem 1997; 272: 2841-2845. (Pubitemid 27053331)
59. Gow AJ, Luchsinger BP, Pawloski JP, Singel DJ, Stamler JS. The oxyhemoglobin reaction of nitric oxide. Proc Natl Acad Sci USA 1999; 96: 9027-9032.
60. Gow AJ, Ischiropoulos H. Nitric oxide chemistry and cellular signalling. J Cell Physiol 2001; 187: 277-282. (Pubitemid 32378352)
61. Kim YM, de Vera ME, Watkins SC, Billiar TR. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-α-induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem 1997; 272: 1402-1411.
62. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-3064.
63. Brunner F, Andrew P, Wolkart G, Zechner R, Mayer B. Myocardial contractile; function and heart rate in mice with myocyte specific overexpression of endothelial nitric oxide synthase. Circulation 2001; 104: 3097-3102. (Pubitemid 34014064)
64. Shaul PW. Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol 2002; 64: 749-774. (Pubitemid 34259248)
65. Di Pietro R, Mariggiò MA, Guarnieri S, Sancilio S, Giardinelli A, Di Silvestre S, et al. TRAIL regulates endothelial Nitric Oxide synthase (eNOS) activity and its localization within Human Vein Endothelial Cells (HUVEC) in culture. J Cell Biochem 2006; 97: 782-794.
66. Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, et al. AMP-activated Protein kinase phosphorylation of endothelial NO synthase? FEBS Lett 1999; 443: 285-289.
67. Haynes V, Elfering S, Traaseth N, Giulivi C. Mitochondrial nitricoxide synthase: enzyme expression, characterization, and regulation. J Bioenerg Biomembr 2004; 36: 341-346.
68. Haughian JM, Reno EM, Thorne AM, Bradford AP. Protein kinase C α-dependent signaling mediates endometrial cancer cell growth and tumorigenesis. Int J Cancer 2009; 125: 2556-2564.
69. Király M, Porcsalmy B, Pataki A, Kádár K, Jelitai M, Molnár B, et al. Simultaneous PKC and cAMP activation induces differentiation of human dental pulp stem cells into functionally active neurons. Neurochem Int 2009; 55: 323-332.
70. Gould CM, Newton AC. The life and death of protein kinase C. Curr Drug Targets 2008; 9: 614-625.
71. Hanauske AR, Sundell K, Lahn M. The role of protein kinase C α in cancer and its modulation by the novel PKCα-specific inhibitor Aprinocarsen. Curr Pharmaceut Design 2004; 10: 1923-1936. (Pubitemid 38647578)
72. Di Giulio C, Rapino M, Zingariello M, Antonucci A, Cataldi A. PKCα mediated CREB activation is oxygen and age-dependent. Histochem Cell Biol 2007; 127: 327-333.
73. Gopalakrishna R, Jaken S. Protein kinase C and oxidative stress Free Rad Biol Med 2000; 28: 1349-1361.
74. Barnett ME, Madgwick DK, Takemoto DJ. Protein kinase C as a stress sensor. Cell Signall 2007; 19: 1820-1829.
75. Nishizuka Y. Protein kinase C and lipid signalling for sustained cellular responses. FASEB J 1995; 9: 484-496.
76. Hug H, Sarre TF. Protein kinase C isoenzymes: divergence in signal transduction? Biochem J 1993; 291: 329-343.
77. Cataldi A, Di Pietro R, Centurione L, Rapino M, Santavenere E, Garaci F, et al. Engagement of PI-3-kinase mediated protein kinase C zeta activation in protecting friend cells from ionizing radiation-induced apoptosis. Int J Oncol 2003; 22: 129-135.
78. Cataldi A, Centurione L, Di Pietro R, Rapino M, Bosco D, Grifone G, et al. Protein kinase C zeta nuclear translocation mediates the occurrence of radioresistance in friend erythroleukemia cells. J Cell Biochem 2003; 88: 144-151.
79. Cataldi A, Miscia S, Centurione L, Rapino M, Bosco D, Grifone G, et al. Role of nuclear PKC delta in mediating caspase-3-upregulation in Jurkat T leukemic cells exposed to ionizing radiation. J Cell Biochem 2002; 86: 553-560.
80. Zara S, Bosco D, Di Giulio C, Antonucci A, Cataldi A. Protein kinase Cα early activates splicing factor SC-35 during post-natal rat heart development. J Biol Regul Homeost Agents 2009; 23: 45-54.
81. di Giacomo V, Rapino M, Miscia S, Di Giulio C, Cataldi A. Dual role of HIF-1α in delivering a survival or death signal in hypoxia exposed human K562 erythroleukemia cells. Cell Biol Int 2009; 33: 49-56.
82. Hunter JC, Korzick DH. Age and sex-dependent alterations in protein kinase C and extracellular regulated kinase1/2(ERK 1/2)in rat myocardium. Mech Ageing Dev 2005; 126: 535-550.
83. Cataldi A, Zingariello M, Rapino M, Zara S, Daniele F, Di Giulio C, et al. Effect of hypoxia and aging on PKC delta-mediated SC-35 phosphorylation in rat myocardial tissue. Anat Rec 2009; 292: 1135-1142.
84. Jewell UR, Kvietikova I, Scheid A, Bauer C, Wenger RH, Gassmann M. Induction of HIF 1 α in response to hypoxia is instantaneous. FASEB J 2001; 15: 1312-1314.
85. Prabhakar NR. Oxygen sensing during intermittent hypoxia: cellular and molecular mechanisms. J Appl Physiol 2001; 90: 1986-1994.
86. Bell EL, Emerling BM, Chandel NS. Mitochondrial regulation of oxygen sensing. Mitochondrion 2005; 5: 322-332.
87. Lahiri S, Roy A, Baby SM, Hoshi T, Semenza GL, Prabhakar NR. Oxygen sensing in the body. Progr Biophys Mol Biol 2006; 91: 249-286.
88. Semenza G. Perspectives on Oxygen Sensing. Cell 1999; 98: 281-284.
89. Semenza G. HIF-1: mediator of physiological and pathophysiological response to hypoxia. J Appl Physiol 2000; 88: 1474-1480.
90. Semenza G. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 2002; 8: S62-7.
91. Semenza G. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3: 721-732.
92. Berra E, Benizri E, Ginouves A, Volmat V, Roux D, Pouyssegur J. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady -state levels of HIF-1 α in normoxia. EMBO J 2003; 22: 4082-4090.
93. Chandel NS, Schumacker PT. Cellular oxygen sensing by mitochondria: old questions, new insight. J Appl Physiol 2000; 88: 1880-1889.
94. Ogita K, Fujinami Y, Kitano M, Yoneda Y. Transcription factor activator protein -1 expressed by kainate treatment can bind to the non-coding region of mitochondrial genome in hippocampus. J Neurosci Res 2003; 73: 794-802.
95. Guseva NV, Taghiyev AF, Sturm MT, Rokhlin OW, Cohen MB. Tumor necrosis factor-related apoptosis-inducing ligand-mediated activation of mitochondria-associated NFKB in prostatic carcinoma cell lines. Mol Cancer Res 2004; 10: 574-584.
96. Heyne K, Mannebach S, Wuertz E, Knaup KX, Mahyar-Roemer M, Roemer K. Identification of a putative p53 binding sequence within the human mitochondrial genome. FEBS Lett 2004; 578: 198-202.
97. Ryu H, Lee J, Impey S, Ratan RR, Ferrante RJ. Antioxidants modulate mitochondrial PKA and increase CREB binding to D-loop DNA of the mitochondrial genome in neurons. Proc Natl Acad Sci USA 2005; 102: 13915-13920.
98. Cammarota M, Paratcha G, Bevilaqua LRM, Levi de Stein M, Lopez M, Pellegrino de Iraldi A, et al. Cyclic AMP-responsive element binding protein in brain mitochondria. J Neurochem 1999; 72: 2272-2277.
99. Shaywitz AJ, Greenberg ME. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Ann Rev Biochem 1999; 68: 821-861.
100. Traver D, Akashi K, Weissman IL, Lagasse E. Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia. Immunity 1998; 9: 47-57. (Pubitemid 28361294)
101. Sassone-Corsi P. Transcription factors responsive to cAMP. Annu Rev Cell Dev Biol 1995; 11: 355-377.
102. Vinson CR, Hai T, Boyd SM. Dimerization specificity of the leucine zipper-containing bZIP motif on DNA binding: prediction and rational design. Genes Dev 1993; 7: 1047-1058.
103. Foulkes NS, Laoide BM, Schlotter F, Sassone-Corsi P. Transcriptional antagonist cAMP-responsive element modulator (CREM) down-regulates c-fos cAMP-induced expression. Proc Natl Acad Sci USA 1991; 88: 5448-5452.
104. Zhang X, Odom DT, Koo SH, Conkright MD, Canettieri G, Best J, et al. Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci USA 2005; 102: 4459-4464.
105. Ameri P, Harris P. Activating transcription factor 4. Int J Biochem Cell Biol 2008; 40: 14-21.
106. Riccio P, Ginty M. What a privilege to reside at the synapse: NMDA receptor signaling to CREB. Nat Neurosci 2002; 5: 389-390. (Pubitemid 34454237)
107. Di Pietro R, di Giacomo V, Caravatta L, Sancilio S, Rana RA, Cataldi A. Cyclic nucleotide response element binding (CREB) protein activation is involved in K562 erythroleukemia cells differentiation. J Cell Biochem 2007; 100: 1070-1079. (Pubitemid 46273029)
108. Caravatta L, Sancilio S, di Giacomo V, Rana R, Cataldi A, Di Pietro R. PI3-K/Akt-dependent activation of cAMP-response element-binding (CREB) protein in Jurkat T leukemia cells treated with TRAIL. J Cell Physiol 2008; 214: 192-200. (Pubitemid 350220074)
109. Chhabra A, Fernando H, Watkins G, Mansel RE, Jiang WG. Expression of transcription factor CREB1 in human breast cancer and its correlation with prognosis. Oncol Rep 2007; 4: 953-958.
110. Lesiak K, Sztiller-Sikorska M, Czyz M. Transcription factors in the development and progression of melanoma. Postepy Hig Med Dosw 2007; 61: 576-595.
111. Detry C, Lamour V, Castronovo V, Bellahcène A. CREB-1 and AP-1 transcription factors JunD and Fra-2 regulate bone sialoprotein gene expression in human breast cancer cells. Bone 2008; 42: 422-431.
112. Sands WA, Palmer TM. Regulating gene transcription in response to cyclic AMP elevation. Cell Signall 2008; 20: 460-466.
113. Pagliarini DJ, Dixon JE. Mitochondrial modulation: reversible phsphorylation takes center stage? Trends Biochem Sci 2008; 31: 26-34.
114. De Rasmo D, Signorile A, Roca E, Papa S. c-AMP response element-binding protein (CREB) is imported into mitochondria and promotes protein synthesis. FEBS J 2009; 276: 4325-4333.
115. Blackburn E. Telomere states and cell fate. Nature 2000; 408: 53-56.
116. Passos JF, Saretzki G, von Zglinicki T. DNA damage in telomeres and mitochondria during cellular senescence: is there a connection? Nucleic Acid Res 2007; 35: 7505-7513.
117. Blackburn E. Switching and signalling at the telomere. Cell 2001; 106: 661-673.
118. Rubio MA, Davalos AR, Campisi J. Telomere length mediates the effects of telomerase on the cellular response to genotoxic stress. Exp Cell Res 2004; 298: 17-27. (Pubitemid 38887303)
119. McEachern MJ, Kranskopf A, Blackburn EH. Telomeres and their control. Annu Rev Genet 2000; 34: 331-338.
120. Von Zglincki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002; 27: 339-344.
121. Cataldi A, Zara S, Rapino M, Zingariello M, di Giacomo V, Antonucci A. p53 and telomerase control rat myocardial tissue response to hypoxia and ageing. Eur J Histochem 2009; 53: 209-216.
122. Von Zglincki T, Saretzki G, Docke W, Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp Cell Res 1995; 220: 186-193.
123. Saretzki G, Murphy MP, von Zglinicki T. Mito Q counteracts telomere shortening and elongates lifespan of fibroblasts under mild oxidative stress. Aging Cell 2003; 141-143.
124. Passos JF, Saretzki G, Ahmed S, Nelson G, Richter T, Peters H, et al. Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent replicative senescence. PloS Biol 2007; 5: 1138-1151. (Pubitemid 46790403)
125. Masutomi K, Possemato R, Wong JM, Currier JL, Tothova Z, Manola JB, et al. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc Natl Acad Sci USA 2005; 102: 8222-8227. (Pubitemid 40800070)
126. Saretzki G. Telomerase, mitochondria and oxidative stress. Exp Gerontol 2009; 44: 485-492.
127. Santos JH, Meyer JN, Skorvaga M, Annab LA, Van Houten B. Mitochondrial hTERT exacerbates free-radical mediated mtDNA damage. Aging Cell 2004; 3: 399-411. (Pubitemid 40246710)
128. Santos JH, Meyer JN, Van Houten B. Mitochondrial localization of telomerase as a determinant for hydrogen-peroxiode induced mitochondrial DNA damage and apoptosis. Mol Genet 2006; 15: 1757-1768. (Pubitemid 43821766)
129. Ahmed S, Passos JF, Birket MJ, Beckman T, Brings S, Peters H, et al. Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress. J Cell Sci 2008; 17: 1046-1053. (Pubitemid 351639423)
130. Haendeler J, Drose S, Buchner N, Jakob S, Altschmied J, Goy C, et al. Mitochondrial telomerase reverse transcriptase binds and protects mitochondrial DNA and function from damage. Arterioscl Thromb Vasc Biol 2009; 29: 929-935.
131. 2, a necessary evil for cell signalling. Science 2006; 312: 1882-1883.
132. Amadio M, Scapagnini G, Laforenza U, Intrieri M, Romeo L, Govoni S, et al. Post-transcriptional regulation of HSP70 expression following oxidative stress in SH-SY5Y cells: the potential involvement of the RNA-binding protein HuR. Curr Pharm Des 2008; 14(26): 2651-2658.
133. Antoniades C, Antonopoulos AS, Bendall JK, Channon K MTargeting redox signaling in the vascular wall: from basic science to clinical practice. Curr Pharm Des 2009; 15(3): 329-342.
134. Balsano C, Alisi AAntioxidant effects of natural bioactive compounds. Curr Pharm Des 2009; 15(26): 3063-3073.